tiprankstipranks

Orin Hirschman Insider Profile

4 Followers
Orin Hirschman, Director at NeuBase Therapeutics, holds 1.64M shares in NeuBase Therapeutics (Ticker: NBSE), holds 381.50K shares in Lightpath Technologies (Ticker: LPTH), holds 0.00 shares in 8X8 (Ticker: EGHT). Most recently, Orin Hirschman Bought ― shares of NeuBase Therapeutics on Apr 13, 2017 for an estimated value of 100.00K.
tipranks
Orin Hirschman

Orin Hirschman
NeuBase Therapeutics (NBSE)
Director

Not Ranked
Orin Hirschman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
55.86%
44.14%
0.00%
A breakdown of Orin Hirschman's holdings

Insider Roles

NeuBase Therapeutics
(NBSE)
Director
Lightpath Technologies
(LPTH)
Ten Percent Owner
8X8
(EGHT)
Ten Percent Owner
Roles that Orin Hirschman holds in companies

Most Profitable Insider Trade

Stock:
NeuBase Therapeutics
(NBSE)
Rating:Informative Buy
Date:Apr 13, 2017 - Apr 13, 2018
Return:-70.60%
The most profitable trade made by Orin Hirschman

Orin Hirschman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NeuBase Therapeutics
Apr 13, 2017
Director
Informative Buy
100.00K
$671.14K
Lightpath Technologies
Ten Percent Owner
$530.28K
Ten Percent Owner
$0.00
List of latest transactions for each holding click on a transaction to see Orin Hirschman's performance on stock

Orin Hirschman insider profile FAQ

What is the percentage of profitable transactions made by Orin Hirschman?
The percentage of profitable transactions made by Orin Hirschman is ―.
    What is the average return per transaction made by Orin Hirschman?
    The average return per transaction made by Orin Hirschman is ―.
      What stocks does Orin Hirschman hold?
      Orin Hirschman holds: NBSE, LPTH, EGHT stocks.
        What was Orin Hirschman’s latest transaction?
        Orin Hirschman latest transaction was an Informative Buy of $100.00K.
          What was Orin Hirschman's most profitable transaction?
          Orin Hirschman’s most profitable transaction was an Informative Buy of NBSE stock on April 13, 2017. The return on the trade was -70.60%.
            What is Orin Hirschman's role in NeuBase Therapeutics?
            Orin Hirschman's role in NeuBase Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.